ESR1 and cancer: In this regard, the stimulatory action elicited by IGF1 has been particularly described for estrogen receptor (ER)-positive breast tumors, where a cross-talk between IGF1R and ER transduction pathways has been shown to regulate critical biological responses like cancer cell proliferation and migration [35–38].